Hello, can you hear me? CAN YOU HEAR ME? If not, this is probably because you are reading this. But actually an estimated 10–15 % of us in the developed world suffer from hearing impairment, predominantly caused by the irreversible loss of sensory hair cells in the cochlea of the inner ear. Our portfolio company Acousia Therapeutics, an investment from our CV IV fund, is here to change this, developing innovative therapies to treat and prevent sensorineural hearing loss. Learn more about Acousia in this interview with Tim Bölke, CEO and CMO of the company.

Tim, please introduce Acousia Therapeutics in less than 10 words.
We are pioneers in developing medicines against hearing loss.

Follow this link to read the complete interview on our Medium blog.